DoD Rare Cancers, Idea Development Award
ID: 353641Type: Posted
Overview

Buyer

Dept. of the Army -- USAMRAA (DOD-AMRAA)

Eligible Applicants

Unrestricted

Funding Category

Science and Technology and other Research and Development

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/353641
Timeline
  1. 1
    Forecast Posted Not available
  2. 2
    Forecast Due Not available
  3. 3
    Posted Apr 19, 2024, 12:00 AM UTC
  4. 4
    Due Sep 23, 2024, 12:00 AM UTC
Description

The Department of the Army, through the U.S. Army Medical Research and Materiel Command (USAMRAA), is offering the FY24 Rare Cancers Research Program (RCRP) Idea Development Award to support innovative research aimed at addressing rare cancers, which are defined as those affecting six or fewer individuals per 100,000 annually in the U.S. This grant opportunity encourages applications that demonstrate a strong scientific rationale and preliminary data relevant to rare cancers, with a focus on potential high-impact advancements in cancer biology, research models, or novel therapeutic strategies. The total estimated funding for this program is $6.16 million, with a maximum request of $350,000 per project for up to three years, and applications are due by September 23, 2024. Interested applicants can reach out to the CDMRP Help Desk at help@eBRAP.org for further assistance.

Point(s) of Contact
help@eBRAP.org
Files
Title
Posted
HT924524RCRPIDA_GG.pdf
Aug 24, 2024, 2:22 AM UTC
The Department of Defense (DOD) is announcing the FY24 Rare Cancers Research Program (RCRP), specifically offering the Idea Development Award to encourage innovative research on rare cancers, defined as those affecting six or fewer people per 100,000 annually in the U.S. The funding opportunity includes a total of $17.5 million for this fiscal year, with a maximum request of $350,000 per project for up to three years. Applicants must demonstrate the relevance of their research to military personnel, veterans, and the general public, and address at least one of the program's focus areas: cancer biology, research models, or novel therapeutic strategies. The submission process follows a two-step approach: pre-application submission via eBRAP and full application via Grants.gov, with strict adherence to deadlines. Eligible applicants include both extramural and intramural organizations, with independent investigators at or above the Assistant Professor level acting as Principal Investigators. The review process will evaluate the applications based on technical merit, impact on rare cancer outcomes, and the overall effectiveness of the proposed research strategy. The program aims to promote research with the potential for significant advancements in addressing rare cancers and improving patient outcomes.
Similar Opportunities
DoD Breast Cancer Breakthrough Award Level 3
Dept. of the Army -- USAMRAA
The Department of the Army, through the US Army Medical Research and Materiel Command (USAMRAA), is offering the FY25 Breast Cancer Breakthrough Award Level 3, aimed at supporting innovative research with the potential to significantly advance breast cancer treatment and prevention. Applicants are required to address at least one of the Department of Defense-defined challenges related to breast cancer, and the research team must include breast cancer consumer advocates to ensure patient perspectives are integrated into the research process. This grant program allocates approximately $27.9 million for three awards, with funding caps of $4 million for single Principal Investigators and $5 million for projects involving a Partnering PI. Pre-applications are due by June 13, 2025, and full applications must be submitted by September 10, 2025. For further inquiries, applicants can contact the CDMRP Help Desk at help@eBRAP.org or call 301-682-5507.
DoD Breast Cancer Breakthrough Award Levels 1 and 2
Dept. of the Army -- USAMRAA
The Department of the Army, through the US Army Medical Research and Materiel Command (USAMRAA), is offering the FY25 Breast Cancer Research Program (BCRP) Breakthrough Award Levels 1 and 2, aimed at supporting innovative research with the potential to significantly advance breast cancer treatment and prevention. This funding opportunity, totaling approximately $37.7 million, seeks to address critical challenges in breast cancer research, including prevention strategies, understanding metastasis, and improving treatment efficacy. Eligible applicants include both domestic and foreign nonprofit and for-profit organizations, with a strong emphasis on collaborative partnerships, particularly those involving military and veteran populations. Interested parties must submit a pre-application by June 13, 2025, followed by a full application due by June 27, 2025. For further inquiries, applicants can contact the CDMRP Help Desk at help@eBRAP.org or by phone at 301-682-5507.
DOD Ovarian Cancer, Pilot Award
Dept. of the Army -- USAMRAA
The Department of the Army, through the US Army Medical Research and Materiel Command (USAMRAA), is offering the FY25 Ovarian Cancer Research Pilot Award, aimed at fostering innovative research in ovarian cancer. This grant opportunity encourages projects that explore groundbreaking concepts and approaches to enhance early detection and prevention strategies, with a focus on significant advancements that can impact patient care. The total funding available is approximately $3.15 million, with nine awards anticipated, each capped at $350,000 for a maximum duration of two years. Interested applicants must submit a pre-application by June 12, 2025, followed by full applications due by September 11, 2025. For further inquiries, applicants can contact the CDMRP Help Desk at 301-682-5507 or via email at help@eBRAP.org.
DOD Ovarian Cancer, Clinical Trial Academy – Early-Career Investigator Award
Dept. of the Army -- USAMRAA
The Department of the Army, through the US Army Medical Research and Materiel Command (USAMRAA), is offering the Ovarian Cancer Clinical Trial Academy – Early-Career Investigator Award for Fiscal Year 2025. This grant aims to support early-career investigators in conducting clinical trials focused on ovarian cancer, emphasizing professional development, intensive mentoring, and networking opportunities. The program is critical for enhancing the research landscape in ovarian cancer, with an estimated total funding of approximately $1.4 million available for a maximum of four years. Interested applicants must submit a pre-application by June 12, 2025, followed by a full application due on September 11, 2025, and can reach out to the CDMRP Help Desk at help@eBRAP.org or by phone at 301-682-5507 for further information.
DoD Breast Cancer Era of Hope Scholar Award
Dept. of the Army -- USAMRAA
The Department of the Army, through the US Army Medical Research and Materiel Command (USAMRAA), is offering the FY25 Breast Cancer Research Program's Era of Hope Scholar Award, aimed at early-career scientists with the potential to innovate in breast cancer research. This grant program, with an estimated total funding of approximately $10.85 million, will support two awards, each capped at $3.5 million for a maximum term of four years. The award emphasizes the importance of innovative research approaches to advance understanding and treatment of breast cancer, requiring Principal Investigators to commit at least 25% of their time to the project and to include two breast cancer consumer advocates in their research teams. Interested applicants must submit a pre-application by June 13, 2025, followed by a full application due by June 27, 2025; for further inquiries, contact the CDMRP Help Desk at help@eBRAP.org or call 301-682-5507.
DoD Breast Cancer Clinical Research Extension Award
Dept. of the Army -- USAMRAA
The Department of the Army, through the US Army Medical Research and Materiel Command (USAMRAA), is offering the Breast Cancer Clinical Research Extension Award as part of the Fiscal Year 2025 Breast Cancer Research Program (BCRP). This grant aims to enhance the impact of breast cancer clinical studies by extending data collection, follow-up, and analysis, specifically addressing challenges such as early trial termination and limited patient follow-up. Approximately $26.35 million is available to fund around three projects, with direct cost caps of $5 million for single Principal Investigators (PIs) and $6 million for partnered PIs, requiring the involvement of at least two breast cancer consumer advocates in the research team. Interested applicants must submit a pre-application by June 13, 2025, followed by a full application due by June 27, 2025, with successful proposals notified within six weeks post-review. For further inquiries, applicants can contact the CDMRP Help Desk at help@eBRAP.org or call 301-682-5507.
Alzheimer’s Research Program Transforming Care Award
Dept. of the Army -- USAMRAA
The Department of the Army, through the US Army Medical Research and Development Command (USAMRAA), is offering the Alzheimer's Research Program Transforming Care Award to support innovative clinical research aimed at improving care for individuals with Alzheimer's disease and related dementias (AD/ADRD). This funding opportunity encourages community collaboration and requires projects to focus on interventions that enhance the quality of life for both patients and their caregivers. Approximately $5.2 million is available to fund around three awards, with pre-applications due by June 12, 2025, and full applications due by August 29, 2025. For further inquiries, applicants can contact the CDMRP Help Desk at help@eBRAP.org or by phone at 301-682-5507.
Alzheimer’s Research Program Transforming Research Award
Dept. of the Army -- USAMRAA
The Department of the Army, through the US Army Medical Research and Development Command (USAMRAA), is offering the Alzheimer's Research Program Transforming Research Award to support innovative research aimed at reducing the risk of Alzheimer's disease and related dementias (AD/ADRD). This grant opportunity encourages diverse applicants, including for-profit, non-profit, and academic institutions, and emphasizes the necessity of community collaboration, particularly for clinical research projects. With an estimated total program funding of $4 million, the program anticipates awarding approximately four grants, each providing up to $1 million over a maximum of three years. Interested applicants must submit a pre-application by June 12, 2025, followed by a full application due by August 29, 2025. For further inquiries, contact the CDMRP Help Desk at help@eBRAP.org or call 301-682-5507.
NCI Small Grants Program for Cancer Research (NCI Omnibus) (R03 Clinical Trial Optional)
National Institutes of Health
The National Institutes of Health (NIH) has announced the NCI Small Grants Program for Cancer Research (R03), aimed at supporting short-term cancer research projects that require limited resources. This funding opportunity encourages diverse research efforts, including pilot studies, secondary data analyses, and the development of research methodologies, with a maximum budget of $50,000 per year for projects lasting up to two years. The program is designed to address significant knowledge gaps in cancer research and is open to a wide range of applicants, including public, private, and foreign entities. Interested parties should note that the application period opens on January 24, 2025, with a submission deadline of February 24, 2025. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov.
NCI Small Grants Program for Cancer Research for Years 2023, 2024, and 2025 (NCI Omnibus) (R03 Clinical Trial Optional)
National Institutes of Health
The National Institutes of Health (NIH), through the National Cancer Institute (NCI), has announced the NCI Small Grants Program for Cancer Research (R03) for the years 2023 to 2025. This funding opportunity is designed to support small-scale research projects on cancer that can be completed within a two-year timeframe and with limited resources, including pilot studies, secondary data analyses, and the development of research methodologies or technologies. Grants of up to $50,000 per year are available to a wide range of eligible applicants, including higher education institutions, nonprofits, and various community organizations. Interested parties should submit their applications electronically via Grants.gov, with the first submission deadline having been January 22, 2023, and subsequent deadlines continuing through 2025. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov.